Controversy and Progress in Alzheimers Disease - FDA Approval of AducanumabNEJM 385:doi:10.1056/NEJMp2111320, Rabinovici, G.D., 2021
Responding to Medical Events During Commercial Airline FlightsNEJM 346:1067-1073, Gendreau,M.A. &DeJohn,C., 2002